Johnson & Johnson confirms opioid business has ended in $230 million settlement with New York

This settlement may be just the first shoe to drop.  J&J division Janssen use to produce Duragesic patches… they have ceased production of that product and the last of the existing stock will expire Jan 31, 2021 – 5-6 weeks from now.  For a pharmaceutical to be FDA approved on the market place it must […]